Invention Grant
- Patent Title: Albumin Fusion Proteins
- Patent Title (中): 白蛋白融合蛋白
-
Application No.: US13464248Application Date: 2012-05-04
-
Publication No.: US08946156B2Publication Date: 2015-02-03
- Inventor: David J. Ballance , Darrell Sleep , Christopher P. Prior , Homayoun Sadeghi , Andrew J. Turner
- Applicant: David J. Ballance , Darrell Sleep , Christopher P. Prior , Homayoun Sadeghi , Andrew J. Turner
- Applicant Address: US MD Rockville DK
- Assignee: Human Genome Sciences, Inc.,Novozymes Biopharma DK A/S
- Current Assignee: Human Genome Sciences, Inc.,Novozymes Biopharma DK A/S
- Current Assignee Address: US MD Rockville DK
- Agency: Baker & Hostetler LLP
- Main IPC: C12N9/96
- IPC: C12N9/96 ; A61K38/48 ; A61K9/00 ; A61K38/21 ; A61K38/38 ; C07K14/56 ; C07K14/61 ; C07K14/62 ; C07K14/65 ; C07K14/705 ; C07K14/715 ; C07K14/76 ; C07K14/765 ; C12N15/62 ; A61K47/48 ; A61K47/42 ; A61K48/00 ; A61K39/00
Abstract:
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acid vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
Public/Granted literature
- US20130266553A1 Albumin Fusion Proteins Public/Granted day:2013-10-10
Information query
